Adjuvant therapy for retroperitoneal sarcoma: a meta-analysis

Abstract excerpt

<title>Abstract</title> <p>Background Adjuvant therapy is a promising treatment to improve the prognosis of cancer patients, however, the evidence base driving recommendations for adjuvant radiotherapy (ART) or chemotherapy (ACT) in retroperitoneal sarcomas (RPS) primarily hinges on observational data. The aim of this study was to evaluate the effectiveness of adjuvant therapy in the management of RPS by pooling...

Topics

Open a Topic to create a Post that cites this publication.

• Carcinoma, Non-Small-Cell Lung
• ErbB Receptors
• Lung Neoplasms
• Mutation
• Neoplasm Metastasis
• Protein Kinase Inhibitors
• Treatment Outcome
• Tyrosine Kinase Inhibitors

Identifiers and source

Literature Corpus work

a64ec5c9-247c-507a-becb-112f94a5f70f

DOI

10.21203/rs.3.rs-128705/v1